Quaker Bioventures invests in Rapid Micro Biosystems - Technical.ly Philly

Business

Jul. 9, 2009 3:23 pm

Quaker Bioventures invests in Rapid Micro Biosystems

Quaker BioVentures, a venture capital firm based in University City's Cira Center, has been on a roll the past month.

Quaker BioVentures, a venture capital firm based in University City’s Cira Center, has been on a roll the past month.

In June, partner David King was named to the board of the University City Science Center and the company was profiled in the Wall Street Journal for shifting some of its resources from biotech to medical devices.

The good news continued yesterday when it was announced that Quaker was one of the Series A investors in Rapid Micro Biosystems, a company that makes technology to detect troublesome microbes that can slow down the drug-making process.

When Technically Philly asked for the exact share Quaker BioVentures invested, the company said it does not disclose amounts.

Rapid Micro’s viral detection technology has already been commercialized and the company hopes the additional investment will help it expand to new markets including Europe.

hgjhghg

Quaker BioVentures partner Richard Kollender

When unwanted microbes sneak into vats where drugs are being made the effect can be disastrous for large drug companies who often have to shut down production and face supply shortages, according to xconomy. Drug-maker Genzyme may stand to lose $300 million in the wake of its plant shutdown over contaminated vats.

The Boston-based Rapid Micro Biosystems secured $18.6 million from three other investors along with Quaker, including California-based Kleiner Perkins Caufield & Byers, Boston-based TVM Capital and Boston-based VIMAC Milestone Medica Fund; leaving Quaker as the lone local representation in the funding round.

Quaker BioVentures partner Richard Kollender will join the board as part of the deal.

Companies: Quaker Partners
People: David King
Projects: Cira Centre
-30-
CONTRIBUTE TO THE
JOURNALISM FUND

Already a contributor? Sign in here
Connect with companies from the Technical.ly community
New call-to-action

Advertisement

University City biotech firm Cabaletta Bio Inc. goes public in $74.8M IPO

Success in life sciences begets more success: What Philly leaders say about the industry’s growth

Money Moves: These 5 Philly-area companies just raised millions in VC funding

SPONSORED

Philly

How ShopRunner’s mentorship program is pushing its employees to think beyond their fields

Philadelphia

Vistar Media

Sr. Software Engineer

Apply Now

Blue Bell, PA

Pinnacle 21

Senior Software Engineers

Apply Now

Philadelphia

Vistar Media

Front End Engineer

Apply Now

A Center City biotech company is using an algorithm to help patients with memory loss

PA Biotech Center just announced a $50M investment fund and accelerator

Philly will host an inaugural pharma conference next month

SPONSORED

Philly

How Relay is helping enterprise clients get proactive about customer engagement

Philadelphia, Pa

Inspire

Event Sales Ambassador

Apply Now

Philadelphia

Linode

Systems Engineer

Apply Now

Philadelphia

Linode

Data Center Operations Engineer

Apply Now

Sign-up for daily news updates from Technical.ly Philadelphia

Do NOT follow this link or you will be banned from the site!